More than 7,000 bottles of duloxetine, a generic version of antidepressant Cymbalta, have been recalled by the FDA due to the presence of N-nitroso-duloxetine, a chemical that is a suspected carcinogen.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
